A 6-Week, Randomized, Multicenter, Double-Blind, Parallel, Flexed- and Fixed-Dose Study of MDX (Metadoxine Extended-Release; MG01CI) Compared With Placebo in Adolescents and Adults With Fragile X Syndrome

New Research Poster Presentation 2.18
A 6-Week, Randomized, Multicenter, Double-Blind, Parallel, Flexed- and Fixed-Dose Study of MDX (Metadoxine Extended-Release; MG01CI) Compared With Placebo in Adolescents and Adults With Fragile X Syndrome

Thursday, October 29, 2015 10:00 AM

Elizabeth Berry-Kravis, MD, Rush University Medical Center, Chicago, IL

Jonathan Rubin, MD, MBA, Alcobra Pharma, Philadelphia, PA

Eran Harary, MD, Alcobra Pharma, Tel Aviv, Israel

Yaron Daniely, MBA, PhD, Alcobra Pharma, Tel Aviv, Israel